Next Generation Sequencing Workshop at the Royal Society of Medicine (London, May 2022): how genomics is on the path to modernizing genetic toxicology
Authors:
- Anthony M LynchALAnthony M Lynch
- Thalita B ZanoniTZThalita B Zanoni
- Jesse J SalkJSJesse J Salk
- Inigo MartincorenaIMInigo Martincorena
- Robert R YoungRYRobert R Young
- Jill KucabJKJill Kucab
- Charles C ValentineCVCharles C Valentine
- Carole YaukCYCarole Yauk
- Kristine L WittKWKristine L Witt
- Roland FrötschlRFRoland Frötschl
- Simon H ReedSRSimon H Reed
Open Access
- 10 June 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Mutagenesis
- Vol. 38 (4) , 192-200
Abstract
The use of error-corrected Next Generation Sequencing (ecNG) to determine mutagenicity has been a subject of growing interest and potentially a disruptive technology that could supplement, and in time, replace current testing paradigms in preclinical safety assessment. Considering this, a Next Generation Sequencing Workshop was held at the Royal Society of Medicine in London in May 2022, supported by the United Kingdom Environmental Mutagen Society (UKEMS) and TwinStrand Biosciences (WA, USA), to discuss progress and future applications of this technology. In this meeting report, the invited speakers provide an overview of the Workshop topics covered and identify future directions for research. In the area of somatic mutagenesis, several speakers reviewed recent progress made with correlating ecNGS to classic in vivo transgenic rodent mutation assays as well as exploring the use of this technology directly in humans and animals, and in complex organoid models. Additionally, ecNGS has been used for detecting off-target effects of gene editing tools and emerging data suggest ecNGS potential to measure clonal expansion of cells carrying mutations in cancer driver genes as an early marker of carcinogenic potential and for direct human biomonitoring. As such, the workshop demonstrated the importance of raising awareness and support for advancing the science of ecNGS for mutagenesis, gene editing, and carcinogenesis research. Furthermore, the potential of this new technology to contribute to advances in drug and product development and improve safety assessment was extensively explored.Keywords
Funding Information
- National Institutes of Health
This publication has 16 references indexed in Scilit:
- Extensive heterogeneity in somatic mutation and selection in the human bladderScience, 2020
- Application of the adverse outcome pathway framework to genotoxic modes of actionEnvironmental and Molecular Mutagenesis, 2019
- A Compendium of Mutational Signatures of Environmental AgentsCell, 2019
- Predictions of genotoxic potential, mode of action, molecular targets, and potency via a tiered multiflow® assay data analysis strategyEnvironmental and Molecular Mutagenesis, 2019
- Somatic mutant clones colonize the human esophagus with ageScience, 2018
- Mutational spectra of aflatoxin B 1 in vivo establish biomarkers of exposure for human hepatocellular carcinomaProceedings of the National Academy of Sciences, 2017
- High burden and pervasive positive selection of somatic mutations in normal human skinScience, 2015
- Monitoring humans for somatic mutation in the endogenous pig‐a gene using red blood cellsEnvironmental and Molecular Mutagenesis, 2011
- Somatic gene mutation and human disease other than cancer: An updateMutation Research - Reviews in Mutation Research, 2010
- Detailed review of transgenic rodent mutation assaysMutation Research - Reviews in Mutation Research, 2005